US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 0.412
  • +0.002+0.54%
Close Dec 13 16:00 ET
  • 0.410
  • -0.002-0.53%
Post 20:01 ET
19.92MMarket Cap-0.20P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics Q3 2024 Earnings Date

Currency：USDNov 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.33M
214.00K
-1.11M
Miss Est.
+289.33%
-37.24%
-83.88%
EPS
-0.55
-0.32
+0.23
Beat Est.
+68.24%
+81.40%
+41.42%
Analyst Rating
Buy

Nov 30, 2024

BioXcel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.242M--
Nov 14, 20242024/Q3214.000K / 1.328M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.242M--
Nov 14, 20242024/Q3214.000K / 1.328M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--

Unlock Free Earnings Estimates

BioXcel Therapeutics Earnings Reports

  • BioXcel Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 14 09:17 ET

  • BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Third Quarter 2024 Financial Results

    Nov 14 07:07 ET

  • BioXcel Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 09:08 ET

  • BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

    Aug 6 07:08 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 30, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data